3417 related articles for article (PubMed ID: 20132535)
1. Gene ontology analysis for RNA-seq: accounting for selection bias.
Young MD; Wakefield MJ; Smyth GK; Oshlack A
Genome Biol; 2010; 11(2):R14. PubMed ID: 20132535
[TBL] [Abstract][Full Text] [Related]
2. GSEPD: a Bioconductor package for RNA-seq gene set enrichment and projection display.
Stamm K; Tomita-Mitchell A; Bozdag S
BMC Bioinformatics; 2019 Mar; 20(1):115. PubMed ID: 30841846
[TBL] [Abstract][Full Text] [Related]
3. A Workflow Guide to RNA-seq Analysis of Chaperone Function and Beyond.
Lang BJ; Holton KM; Gong J; Calderwood SK
Methods Mol Biol; 2018; 1709():233-252. PubMed ID: 29177664
[TBL] [Abstract][Full Text] [Related]
4. Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer.
Lai J; An J; Nelson CC; Lehman ML; Batra J; Clements JA
Biol Chem; 2014 Sep; 395(9):1127-32. PubMed ID: 25153393
[TBL] [Abstract][Full Text] [Related]
5. Gene dispersion is the key determinant of the read count bias in differential expression analysis of RNA-seq data.
Yoon S; Nam D
BMC Genomics; 2017 May; 18(1):408. PubMed ID: 28545404
[TBL] [Abstract][Full Text] [Related]
6. Investigation of key genes associated with prostate cancer using RNA-seq data.
Wu J; Feng F; Yang D; Yu S; Liu J; Gao Z
Int J Biol Markers; 2014 Mar; 29(1):e86-92. PubMed ID: 24366848
[TBL] [Abstract][Full Text] [Related]
7. Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.
Munkley J; Maia TM; Ibarluzea N; Livermore KE; Vodak D; Ehrmann I; James K; Rajan P; Barbosa-Morais NL; Elliott DJ
F1000Res; 2018; 7():1189. PubMed ID: 30271587
[No Abstract] [Full Text] [Related]
8. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data.
Feng H; Li T; Zhang X
BMC Genomics; 2018 Aug; 19(Suppl 6):564. PubMed ID: 30367578
[TBL] [Abstract][Full Text] [Related]
9. A new RNA-seq method to detect the transcription and non-coding RNA in prostate cancer.
Zhang XM; Ma ZW; Wang Q; Wang JN; Yang JW; Li XD; Li H; Men TY
Pathol Oncol Res; 2014 Jan; 20(1):43-50. PubMed ID: 24043589
[TBL] [Abstract][Full Text] [Related]
10. A novel model used to detect differential splice junctions as biomarkers in prostate cancer from RNA-Seq data.
Rezaeian I; Tavakoli A; Cavallo-Medved D; Porter LA; Rueda L
J Biomed Inform; 2016 Apr; 60():422-30. PubMed ID: 26992567
[TBL] [Abstract][Full Text] [Related]
11. Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.
Coutinho-Camillo CM; Salaorni S; Sarkis AS; Nagai MA
Cancer Genet Cytogenet; 2006 Apr; 166(2):130-8. PubMed ID: 16631469
[TBL] [Abstract][Full Text] [Related]
12. Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients.
Nikitina AS; Sharova EI; Danilenko SA; Butusova TB; Vasiliev AO; Govorov AV; Prilepskaya EA; Pushkar DY; Kostryukova ES
Oncotarget; 2017 May; 8(20):32990-33001. PubMed ID: 28380430
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome.
Rajan P; Dalgliesh C; Carling PJ; Buist T; Zhang C; Grellscheid SN; Armstrong K; Stockley J; Simillion C; Gaughan L; Kalna G; Zhang MQ; Robson CN; Leung HY; Elliott DJ
PLoS One; 2011; 6(12):e29088. PubMed ID: 22194994
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome profiling of the cancer and normal tissues from gastric cancer patients by deep sequencing.
Zhang FG; He ZY; Wang Q
Tumour Biol; 2014 Aug; 35(8):7423-7. PubMed ID: 24777338
[TBL] [Abstract][Full Text] [Related]
15. Androgens down-regulate myosin light chain kinase in human prostate cancer cells.
Léveillé N; Fournier A; Labrie C
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):174-9. PubMed ID: 19429448
[TBL] [Abstract][Full Text] [Related]
16. Gene set enrichment analysis of RNA-Seq data: integrating differential expression and splicing.
Wang X; Cairns MJ
BMC Bioinformatics; 2013; 14 Suppl 5(Suppl 5):S16. PubMed ID: 23734663
[TBL] [Abstract][Full Text] [Related]
17. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
[TBL] [Abstract][Full Text] [Related]
18. Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosis.
Pinskaya M; Saci Z; Gallopin M; Gabriel M; Nguyen HT; Firlej V; Descrimes M; Rapinat A; Gentien D; Taille A; Londoño-Vallejo A; Allory Y; Gautheret D; Morillon A
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31732695
[TBL] [Abstract][Full Text] [Related]
19. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.
Love HD; Booton SE; Boone BE; Breyer JP; Koyama T; Revelo MP; Shappell SB; Smith JR; Hayward SW
PLoS One; 2009 Dec; 4(12):e8384. PubMed ID: 20027305
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR
Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
